Sonoma Pharmaceuticals Q2 2026 Results: Net Loss of $66K, Loss Narrows
Sonoma Pharmaceuticals reported a significant revenue increase to $13.58 million for the six months ended September 30, 2026, compared to $9.62 million in the prior year. The company successfully narrowed its net loss to $396,000 from $1.78 million, driven by improved gross profits and a return to positive income from operations in the most recent quarter.
- Key figure
- Net loss $66K